Improved potency of F10 relative to 5-fluorouracil in colorectal cancer cells with p53 mutations

AIM: Resistance to fluoropyrimidine drugs (FPs) is a major cause of mortality in colorectal cancer (CRC). We assessed the potency advantage of the polymeric FP F10 relative to 5-fluorouracil (5FU) in four human CRC cell lines that differ only in TP53 mutational status to determine how p53 mutations...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominijanni, Anthony, Gmeiner, William H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320232/
https://www.ncbi.nlm.nih.gov/pubmed/30613833
http://dx.doi.org/10.20517/cdr.2018.01

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6320232/
https://www.ncbi.nlm.nih.gov/pubmed/30613833
http://dx.doi.org/10.20517/cdr.2018.01

Ejemplares similares